Cargando…
Advanced prostate cancer – patient survival and potential impact of enzalutamide and other emerging therapies
The advent of exponential growth of novel agents tested and approved for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) has brought about a need for understanding of the mechanism of action, side-effects, and clinical efficacy of these drugs as they relate to...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144843/ https://www.ncbi.nlm.nih.gov/pubmed/25170270 http://dx.doi.org/10.2147/TCRM.S57509 |